logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology


Research lines

. Parenteral nutrition

 

. Pharmacotechnia

 

. Pharmacokinetics


Selected papers (2013)

 

Fábregas A., Miñarro M., García Montoya E., Pérez Lozano P., Carrillo C., Sarrate R., Sánchez N., Ticó J.R., Suñé Negre J.M.

Impact oh physical parameters on particle size and reaction yield when using the ionic gelation method for obtain cationic polymeric chitosan-tripolyphosphate nanoparticle.

International Journal of Pharmaceutics. 2013; 446: 199-204.

 

Rigo-Bonnin R., Padullés A., Corral-Comesaña S., Cerezo G., Grinyó J.M., Colom H., Lloberas N., Alía-Ramos P.

Measurement of ganciclovir concentration in human plasma by ultra-performance liquid chromatography-tandem mass spectrometry.

Clinical Chemistry and Laboratory Medicine. 2014 Jan 1;427:58-64.

 

Carrillo C., Sánchez Hernández N., García Montoya E., Pérez Lozano P., Suñé Negre J.M., Ticó J.R., Suñé C., Miñarro M.

DNA delivery via cationic solid lipid nanoparticles (SLNs).

European Journal of Pharmaceutical Sciences. 2013 (49): 157-165

 

Llaudó I., Colom H., Giménez-Bonafé P., Torras J., Caldés A., Sarrias M., Cruzado J.M., Oppenheimer F., Sánchez-Plumed J., Gentil M.Á., Ekberg H., Grinyó J.M., Lloberas N.

Do drug transporter (ABCB1) SNPs and P-glycoprotein function influence cyclosporine and macrolides exposure in renal transplant patients? Results of the pharmacogenomic substudy within the symphony study.

Transplantion International.2013 Feb;26(2):177-86.

 

García Montoya E., Guerrero Martínez M., Suñé Negre J.M., Pérez Lozano P., Ticó Grau J.R., Miñarro Carmona M.

Design and formulation of nanospheres for sustained release of indomethacine. Basic&Clinical Pharmacology&Toxicology. 2013; 113 (Suppl. 1): 19.

 

García Montoya E., Civit García N., Suñé Negre J.M., Bonet Clols F., Bel prieto E., Pérez Lozano P., Ticó Grau J.R., Miñarro Carmona M.

Drugs and rare diseases: could they be developed at universities?

 Basic&Clinical Pharmacology&Toxicology. 2013; 113 (Suppl. 1): 39-40.

imatge personal
 

Group leader

Josep manuel Llop
Telephone  
+34 933357011
E-mail  
jllop@idibell.cat
 
© 2017 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell